Fig. 2From: Development and validation of an LC-MS/MS method for monitoring larotrectinib, a tropomyosin-related kinase inhibitor, in mouse and human plasma and application to pharmacokinetic studiesRepresentative MRM chromatograms of a double blank plasma, b blank plasma spiked with IS, and c blank plasma spiked 5 ng/mL (LLOQ) of larotrectinib and ISBack to article page